Rare Pediatric Diseases Research Grant Program
Florida Department of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Feb 13, 2026
- Closes
- Oct 26, 2026
Similar opportunities open now
- Ed and Ethel Moore Alzheimer’s Disease Research ProgramSame funderOpenFlorida Department of HealthCloses Oct 20, 2026
- Florida Cancer Innovation FundSame funderOpenFlorida Department of HealthCloses Nov 7, 2026 (in 22 days)
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)OpenFood and Drug AdministrationCloses Feb 2028Up to $600K
- Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)OpenFood and Drug AdministrationCloses May 2028Up to $900K
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jul 2028
Amount
Amount not listed here. Check the official program.
Who can apply
6.1 Applicants According to subsection 381.991(2)(a), Florida Statutes, applications for biomedical research funding may be submitted by any Florida-based university or established research institute. Additionally, to be considered eligible, all the following guidelines must be met. Grant applications failing to meet the eligibility requirements will be rejected. 1. All grant-funded activities must take place in Florida. All work (effort) must occur and all funds must be spent in Florida by the applicant and any collaborators or consortium partners. However, the Department may make exceptions if the service is essential and only provided outside Florida, and if the amount is less than 10% of the award amount. 2. Subcontracts must be pre-approved in the Biomedical Research Section’s budget ...
About this opportunity
Rare Pediatric Diseases Research Grant Program Grants for improved treatment or care delivery that contributes to a reduction in mortality and screenings to increase early detection or prevention for rare pediatric diseases. Required letter of intent deadline: October 26, 2026 at 12:00 PM ET. Full application deadline: December 10, 2026 at 12:00 PM ET. Submit the required LOI before preparing the full application.